Director Hta & Decision Science

Johnson & Johnson Johnson & Johnson · Pharma · Beerse, Antwerp, Belgium +2

This role is for a Director of Health Technology Assessment & Decision Science at Johnson & Johnson. The primary focus is on informing internal decision-making for clinical development programs, evidence generation, and market access strategies by translating HTA agency and payer insights into actionable inputs. The role also involves leading early HTA agency advice activities and contributing to EU Joint Clinical Assessment strategy. While the role mentions leveraging generative AI, its core function is not AI development but rather applying insights to market access and decision science within the healthcare domain.

What you'd actually do

  1. Inform and support internal decision making at internal stage gate, governance meetings and functional advisory meetings by translating HTA agency, payer and health system insights and benchmarks for key markets (incl. US, Japan, EU G4, UK) into actionable decision‑science inputs for development programs and access & evidence generation strategies. Leverage generative AI to enable and enhance internal decision making.
  2. leading, supporting and delivering early HTA agency advice activities, including individual agency and multi-agency procedures (e.g. EU Joint Scientific Consultations) across the portfolio, in collaboration with product teams.
  3. Represent HTA & DS in EU Joint Clinical Assessment (EU JCA) dossier teams, shaping and contributing to delivering PICO strategy and informing dossier development strategy. Ensure cross-program consistency and sharing of key lessons learned.
  4. Provide Market Access technical and scientific review at Protocol Review Committee to ensure patient‑ and payer‑relevant study designs.
  5. Contribute to and deliver HTA capability development, internal briefings, external positioning documents, and external thought leadership.

Skills

Required

  • Advanced degree (MSc, PhD, PharmD, MD, or equivalent) in a relevant discipline (eg., Epidemiology, Biostatistics, (health) Economics, HTA, Medicine, Public Health).
  • At least 7 years of experience in HTA, market access, evidence generation, or related fields, in a pharmaceutical organization and/or external agency.
  • Strong R&D acumen
  • Experience working across multiple therapeutic areas (ideally including one or more of Oncology, Immunology, Neuroscience, Cardiopulmonary) and phase 2, 3 development and launch phases.
  • Strong understanding of international health care, HTA, payer and regulatory environments, with one or more of Europe, the US, and Japan preferred.
  • Global mindset with proven ability to lead, influence, and collaborate across diverse global, cross‑functional teams.
  • Strong strategy development capabilities with the ability to understand, synthesize and translate complex evidence into scenario planning and actionable directions.
  • Advanced analytical and critical thinking skills.
  • Intellectual curiosity and creativity to challenge existing approaches and develop innovative solutions.
  • Clear, confident communicator (verbal and written).
  • Ability to plan, prioritize, and deliver work effectively in a highly matrixed environment with competing demands.
  • Demonstrated commitment to continuous learning and capability development.

Nice to have

  • Agility Jumps
  • Commercial Awareness
  • Competitive Landscape Analysis
  • Cross-Functional Collaboration
  • Customer Intelligence
  • Global Market
  • Go-to-Market Strategies
  • Health Economics
  • Health Intelligence
  • Market Knowledge
  • Market Opportunity Assessment
  • Mentorship
  • Pricing Strategies
  • Regulatory Compliance
  • Strategic Change
  • Tactical Planning
  • Technical Credibility

What the JD emphasized

  • Leverage generative AI to enable and enhance internal decision making